Literature DB >> 26681212

Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis.

M Wei1, Z Y Wu1, J H Lin1, Y Li2, Z X Qian3, Y Q Xie1, H Su1, W Zhou1.   

Abstract

In this study, we identified potential serum biomarkers for the diagnosis of active tuberculosis (TB) and screening for latent TB infections (LTBIs). Peripheral blood samples from 40 healthy individuals, 40 patients with TB, and 40 LTBI individuals were stimulated with the TB-specific antigens ESAT-6 and CFP-10. Human inflammatory cytokine arrays were used to detect the expression of inflammatory cytokines. Cytokines with significant changes were screened to construct a cytokine regulation network. The levels of the cytokines CCL1 (I-309), CXCL9 (MIG), IL-10, IL-6, CSF2, CSF3, IL-8, IL-1α, IL-7, TGF-β1, CCL2, IL-2, IL-13, and TNFα were significantly upregulated in the active TB group. The levels of CCL3, IL-1β, CCL8, IFNγ, and CXCL10 were significantly increased in the TB groups compared to those in the healthy control group. sTNF RII was upregulated in the LTBI group. CCL4 and MIP1d were significantly increased in all groups.The upregulated cytokines were mainly found in the IFNγ and IL-1α regulatory networks. Importantly, we found that CXCL10 (IP-10), CCL3, CCL8, and IL-1β may be more suitable than IFNγ for active or latent TB infection screening. Furthermore, we found that levels of CCL1 (I-309), CXCL9 (MIG), IL-10, IL-6, CSF2, CSF3, IL-8, IL-1α, IL-7, TGF-β1, CCL2, IL-2, and IL-13 after TB antigen stimulation may help distinguish between active and latent TB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26681212     DOI: 10.4238/2015.December.16.18

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  7 in total

1.  Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatment.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Subash Babu
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

2.  Tuberculosis patients display a high proportion of CD8+ T cells with a high cytotoxic potential.

Authors:  Leslie Chávez-Galán; Jhacqueline Illescas-Eugenio; Magaly Alvarez-Sekely; Renata Baez-Saldaña; Raúl Chávez; Ricardo Lascurain
Journal:  Microbiol Immunol       Date:  2019-07-26       Impact factor: 1.955

3.  Interleukin 8 and Pentaxin (C-Reactive Protein) as Potential New Biomarkers of Bovine Tuberculosis.

Authors:  Xintao Gao; Xiaoyu Guo; Ming Li; Hong Jia; Weidong Lin; Lichun Fang; Yitong Jiang; Hongfei Zhu; Zhifang Zhang; Jiabo Ding; Ting Xin
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  Arabinogalactan enhances Mycobacterium marinum virulence by suppressing host innate immune responses.

Authors:  Ye-Yu Li; Han-Mei Liu; Decheng Wang; Yan Lu; Cairong Ding; Li-Shuang Zhou; Xiang-Yang Wu; Zi-Wei Zhou; Shu-Qin Xu; Chen Lin; Lian-Hua Qin; Yao Li; Jun Liu; Hai-Peng Liu; Lu Zhang
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

5.  Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.

Authors:  Ah Young Leem; Joo Han Song; Eun Hye Lee; Hyejon Lee; Bora Sim; Song Yee Kim; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Joon Chang; Young Ae Kang
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

6.  Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review.

Authors:  Mariana Herrera; Cristian Vera; Yoav Keynan; Zulma Vanessa Rueda
Journal:  J Immunol Res       Date:  2020-04-21       Impact factor: 4.818

7.  High sensitivity and specificity of a 5-analyte protein and microRNA biosignature for identification of active tuberculosis.

Authors:  Jessica L Pedersen; Simone E Barry; Nilesh J Bokil; Magda Ellis; YuRong Yang; Guangyu Guan; Xiaolin Wang; Alen Faiz; Warwick J Britton; Bernadette M Saunders
Journal:  Clin Transl Immunology       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.